Concepedia

Heather Sevinsky

HS

Statistics

Publications

13

Citations

330

H-Index

11

Active since

2010

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (France)

Bristol-Myers Squibb (Sweden)

GlaxoSmithKline (United States)

Heather Sevinsky is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, antiretroviral therapy, and pharmacokinetics.

Publications per year

2010–2022

13

Publications

13

Assessment of Pharmacokinetic Interactions of the HCV Ns5A Replication Complex Inhibitor Daclatasvir with Antiretroviral Agents: Ritonavir-Boosted Atazanavir, Efavirenz and Tenofovir

Marc Bifano, Carey Hwang, B. Oosterhuis et al. · Antiviral Therapy · 2013 · 95 citations

, , +17

The Effect of Efavirenz on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy HIV-Negative Women

Heather Sevinsky, Timothy Eley, Anna Persson et al. · Antiviral Therapy · 2010 · 61 citations

, , +15

Brief Report

Jan van Lunzen, Anton Pozniak, José M. Gatell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 23 citations · Full text

, , +17

Antiviral Activity, Safety, and Exposure–Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002)

Carey Hwang, Dirk Schürmann, Christian Sobotha et al. · Clinical Infectious Diseases · 2017 · 23 citations · Full text

, , +17

The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus

Timothy Eley, Heather Sevinsky, Shu‐Pang Huang et al. · Clinical Drug Investigation · 2014 · 20 citations

, , +11

1–5 of 13